innovation for industry
News | Institutional
Liste de actualités du Leti
CEA-Leti recently completed an equipment collaboration with SET (Smart Equipment Technology) for its direct hybrid bonding die-to-wafer process that combines precise alignment (under 1 micron) and high throughput. In collaboration with Intel, CEA-Leti is also exploring another die-to-wafer process that could multiply current production speeds by four.
CEA-Leti research leads to improved MEMS micro-mirrors for vehicles. This innovative technology aims to detect car tires (15cm high) from a distance of 100 meters. These research results emerged from the European Vizta project and are protected by three new patents.
Whether it’s medical deserts, overcrowded hospital wards, or a lack of solutions for patients too sick to move, medical radiology is no stranger to today’s healthcare challenges.
CEA and Schneider Electric, the global leader in the digital transformation of energy management and automation, have agreed to extend their joint laboratory collaboration for three more years. The shared objective is to continue to test and fortify the security of world-leading process-and-energy technologies for greater resilience across industries.
CEA-Leti and Astrocast have announced their successful collaboration on a low-cost, bidirectional communication module that enables corporations to communicate with their remote assets in areas not covered by terrestrial networks.
Valeo and the French Alternative Energies and Atomic Energy Commission (CEA) signed an agreement to collaborate on the next generations of power electronics, which are at the heart of the challenges facing tomorrow's electric mobility.
CEA-Leti invites decision makers on the lookout for innovative and promising chip-based R&D, as well as editors, analysts and entrepreneurs to peruse the institute's reader-friendly "2021 Highlights" report
CEA-Leti, Université Grenoble Alpes, CNRS Institut Néel, and CEA-Irig shared a new three-step characterization chain for linear silicon quantum dot (QD) arrays fabricated on fully depleted silicon-on-insulator (FDSOI) material.
A new diagnostic technology could help confirm heart attacks faster and more cost-effectively than conventional antibody screening. Proof-of-concept testing was completed successfully on blood-clotting enzyme thrombin, which means that the technology could potentially be used to detect troponin, a cardiovascular disease biomarker. The goal is to improve patient care through faster, more affordable testing.
Inspired by the barn owl’s neuroanatomy, CEA-Leti has developed an event-driven, object-localization system that couples state-of-the-art piezoelectric, ultrasound transducer sensors to a neuromorphic, resistive memories-based computational map.
To address the shortage of semi-conductors which continues to impact many sectors, including the automotive industry, and meet the growing need for electronic components, its production capacities must significantly increase.
CEA-Leti is working with MIT on new sensors capable of weighing the tiniest individual particles to provide valuable information about their nature.
OWARD has been awarded a grant from the European Innovation Council (EIC) to support the development of an innovative Brain-Spine Interface technology for restoring mobility and upper limb function.
The startup Remedee Labs has designed the first endorphin stimulator for individual use, with the aim of providing an answer to patients' chronic pain.
Spectronite turned to CEA-Leti to boost the spectral efficiency of its wireless point-to-point backhaul solutions for 5G networks.
Atomic force microscopy was used to identify new markers, independent of conventional imaging, that can help delineate pituitary adenomas for more accurate removal.
Paper at ECTC presents success with self-assembly process that uses capillary forces of water to align dies on target devices for possible memory, HPC and photonic applications
Researchers collaborating within the European project New Deal have developed an unprecedented therapy for treating chronic inflammatory bowel diseases such as Crohn’s disease. The initial results, from in vitro and pre-clinical tests, are promising.
A new approach to breast cancer screening leveraging two imaging techniques—ultrasound and optical—is now in clinical trials.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.